{"id":349521,"date":"2026-11-17T10:12:55","date_gmt":"2026-11-17T04:42:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=349521"},"modified":"2026-11-17T10:12:55","modified_gmt":"2026-11-17T04:42:55","slug":"why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"Aarti Pharmalabs (AARTIPHARM) 52 Week High Streak: Stock Hits Fresh High for Second Straight Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\">Aarti Pharmalabs Ltd. (AARTIPHARM)<\/a> share price reached a fresh 52-week high of Rs 1,033.6 today and later stood at Rs 1,032.95, up 4.74% from the previous close. Market cap was Rs 9,062.09 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Aarti Pharmalabs 52 Week High Streak: <a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\">Aarti Pharmalabs Ltd. (AARTIPHARM)<\/a> has now set a fresh 52-week high for its second straight session, taking the cumulative move across the run to 3.36% since 16 November 2026. The stock touched a peak of Rs 1,033.60 and was trading at Rs 1,032.95 as of 17 November 2026 at 10:07 AM IST. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">Against the previous close of Rs 986.25, the stock is up Rs 46.70, or 4.74%, after opening at Rs 999.00 and touching a low of Rs 980.20. Market capitalisation stands at Rs 9,062.09 crore. Unlike a single-day breakout, the Aarti Pharmalabs 52 Week High Streak shows a repeated one-year high on back-to-back sessions, which makes the cumulative move and the valuation after it the more useful reference points.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Aarti_Pharmalabs_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Aarti Pharmalabs 52 Week High Streak: Consecutive High Analysis\">Aarti Pharmalabs 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Aarti_Pharmalabs_Ltd_AARTIPHARM_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Aarti Pharmalabs Ltd. (AARTIPHARM) 52 Week High Streak: Consecutive High Analysis\">Aarti Pharmalabs Ltd. (AARTIPHARM) 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Aarti_Pharmalabs_Ltd_AARTIPHARM_Fundamental_Analysis\" title=\"Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis\">Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Aarti_Pharmalabs\" title=\"Why Investors Are Watching Aarti Pharmalabs\">Why Investors Are Watching Aarti Pharmalabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#About_Aarti_Pharmalabs\" title=\"About Aarti Pharmalabs\">About Aarti Pharmalabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Track_Aarti_Pharmalabs_on_Univest\" title=\"Track Aarti Pharmalabs on Univest\">Track Aarti Pharmalabs on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#How_many_sessions_has_Aarti_Pharmalabs_set_a_52-week_high\" title=\"How many sessions has Aarti Pharmalabs set a 52-week high?\">How many sessions has Aarti Pharmalabs set a 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#What_is_the_Aarti_Pharmalabs_52_Week_High_Streak_gain\" title=\"What is the Aarti Pharmalabs 52 Week High Streak gain?\">What is the Aarti Pharmalabs 52 Week High Streak gain?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Why_is_Aarti_Pharmalabs_hitting_new_52-week_highs\" title=\"Why is Aarti Pharmalabs hitting new 52-week highs?\">Why is Aarti Pharmalabs hitting new 52-week highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#What_is_the_Aarti_Pharmalabs_share_price_today\" title=\"What is the Aarti Pharmalabs share price today?\">What is the Aarti Pharmalabs share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#What_is_the_Aarti_Pharmalabs_market_cap\" title=\"What is the Aarti Pharmalabs market cap?\">What is the Aarti Pharmalabs market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#What_are_the_PE_and_PB_ratios_of_Aarti_Pharmalabs\" title=\"What are the P\/E and P\/B ratios of Aarti Pharmalabs?\">What are the P\/E and P\/B ratios of Aarti Pharmalabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#How_does_Aarti_Pharmalabs_compare_with_the_Pharmaceuticals_Drugs_industry\" title=\"How does Aarti Pharmalabs compare with the Pharmaceuticals &amp; Drugs industry?\">How does Aarti Pharmalabs compare with the Pharmaceuticals &amp; Drugs industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#How_does_Aarti_Pharmalabs_compare_with_its_peers\" title=\"How does Aarti Pharmalabs compare with its peers?\">How does Aarti Pharmalabs compare with its peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-aarti-pharmalabs-ltd-share-52-week-consecutive-high-2026\/#Track_Aarti_Pharmalabs_Ltd_AARTIPHARM_Share_Price_on_Univest\" title=\"Track Aarti Pharmalabs Ltd. (AARTIPHARM) Share Price on Univest\">Track Aarti Pharmalabs Ltd. (AARTIPHARM) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Aarti_Pharmalabs_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Aarti Pharmalabs 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Aarti Pharmalabs 52 Week High Streak is now two sessions old. Univest data shows a fresh 52-week high on 16 November 2026 and again on 17 November 2026, with the current 52-week high at Rs 1,033.60. That level equals today&#8217;s day high, so the latest peak was set during the current session.<\/p>\n<p>Across the run, Aarti Pharmalabs has moved 3.36% cumulatively. Today&#8217;s contribution is Rs 46.70, or 4.74%, from a previous close of Rs 986.25 to the latest traded price of Rs 1,032.95. The day opened at Rs 999.00, touched a low of Rs 980.20 and then reached Rs 1,033.60, so the latest traded price sits at the very top of the day&#8217;s range.<\/p>\n<p>Market capitalisation is Rs 9,062.09 crore as of 10:07 AM IST. This Aarti Pharmalabs 52 Week High Streak reading is about price only. Univest data confirms the repeated highs but does not establish a company-specific catalyst, so the move is best read as a price event and not as a response to a confirmed development. Because the session is still open, the latest traded price and the day&#8217;s high can change as trading continues.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aarti_Pharmalabs_Ltd_AARTIPHARM_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Aarti Pharmalabs Ltd. (AARTIPHARM) 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,032.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 986.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 46.7 (+4.74%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 999<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,033.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 980.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,062.09 crore<\/td>\n<\/tr>\n<\/table>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 1,032.95 versus the previous close of Rs 986.25, a rise of 4.74%. The stock opened at Rs 999, reached a high of Rs 1,033.6 and touched a low of Rs 980.2.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Repeated 52-week highs show that the stock has kept moving above its own one-year peak on consecutive sessions. They confirm a price pattern, not a reason. In the Aarti Pharmalabs 52 Week High Streak, the cumulative move of 3.36% is the figure that a single-session reading cannot show.<\/p>\n<p>The pattern carries two readings, and both stay within what the data states. First, the stock has moved above its yearly peak twice in a row, which is what the &#8220;second straight session&#8221; label records. Second, today&#8217;s change of 4.74% is larger than the cumulative 3.36%, so the full Aarti Pharmalabs 52 Week High Streak is a smaller figure than the move on the latest day alone.<\/p>\n<p>A repeated high does not say how long the run will last, and it does not say that the next session will extend it. It also does not say that the move rests on a business development, since Univest data does not establish a catalyst. Readers tracking the Aarti Pharmalabs 52 Week High Streak can compare the current price of Rs 1,032.95 with the 52-week high of Rs 1,033.60 as the session progresses, and watch whether the stock records a third straight session at a fresh one-year high.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aarti_Pharmalabs_Ltd_AARTIPHARM_Fundamental_Analysis\"><\/span><strong>Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,062.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 248.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.35%<\/td>\n<\/tr>\n<\/table>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P\/E 34.84x, P\/B 3.97x, ROE 8.5%, ROCE 10.77%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Aarti Pharmalabs Ltd. has a market capitalisation of Rs 9,062.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 34.84x, P\/B at 3.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 28.31, book value per share of Rs 248.65, dividend yield of 0.35%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.35x, median ROE of 11.43%, median ROCE of 13.1%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">34.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">52.2x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.82x to 1,227.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.97x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,062.09 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 756.71 crore<\/td>\n<\/tr>\n<\/table>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) has a P\/E ratio of 34.84x, which is above the benchmark median of 30.35x, a difference of +14.79%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.43%, a difference of -25.63%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.1%, a difference of -17.79%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pghl\/procter-and-gamble-health-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Procter &amp; Gamble Health Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PGHL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,295.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.86<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/star\/strides-pharma-science-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Strides Pharma Science Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">STAR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,350.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.57<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanoficonr\/sanofi-consumer-healthcare-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi Consumer Healthcare India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFICONR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,329.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">73.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/bluejet\/blue-jet-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Blue Jet Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLUEJET<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10,201.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.18<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>SYMBIOTEC PHARMALAB LTD<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SYMBIOTEC<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10,371.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">91.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.41<\/td>\n<\/tr>\n<\/table>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) has a P\/E ratio of 34.84x compared with the displayed peer median of 29.78x. The comparison is relative and should not be read as a recommendation. Its ROE of 8.5% compares with a peer median of 20.31% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 9,062.09 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Aarti_Pharmalabs\"><\/span><strong>Why Investors Are Watching Aarti Pharmalabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Aarti Pharmalabs has set a fresh 52-week high for its second straight session.<\/li>\n<li>The cumulative move across the streak is 3.36%.<\/li>\n<li>The latest traded price of Rs 1,032.95 is close to the 52-week high of Rs 1,033.60.<\/li>\n<li>The P\/E of 34.84 is 14.79% above the same-industry median of 30.35.<\/li>\n<li>ROE of 8.50% and ROCE of 10.77% are below their industry medians of 11.43% and 13.1%.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Aarti_Pharmalabs\"><\/span><strong>About Aarti Pharmalabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aarti Pharmalabs Ltd. (AARTIPHARM) is a listed company in the Healthcare sector, classified under Pharmaceuticals &amp; Drugs. Its market capitalisation is Rs 9,062.09 crore. For readers following the Aarti Pharmalabs 52 Week High Streak, the relevant context is the industry it is benchmarked against: pharmaceutical companies are commonly read through P\/E, P\/B and return ratios, which is why the P\/E of 34.84, the P\/B of 3.97, the ROE of 8.50% and the ROCE of 10.77% sit alongside the price move in this article. The company&#8217;s position against 198 same-industry companies is covered in the sector section above.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Aarti_Pharmalabs_on_Univest\"><\/span><strong>Track Aarti Pharmalabs on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Univest carries the latest share price, 52-week high, valuation ratios and peer figures for Aarti Pharmalabs Ltd. Readers following the Aarti Pharmalabs 52 Week High Streak can check the stock page as the session progresses to see whether the stock records a further fresh 52-week high, and compare the updated price with the figures in this article.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Aarti_Pharmalabs_set_a_52-week_high\"><\/span><strong>How many sessions has Aarti Pharmalabs set a 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Pharmalabs has set a fresh 52-week high for its second straight session, on 16 November 2026 and again on 17 November 2026. The current 52-week high is Rs 1,033.60, and the Aarti Pharmalabs 52 Week High Streak is two sessions old as of 10:07.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Aarti_Pharmalabs_52_Week_High_Streak_gain\"><\/span><strong>What is the Aarti Pharmalabs 52 Week High Streak gain?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the Aarti Pharmalabs 52 Week High Streak is 3.36%. Today&#39;s change is Rs 46.70, or 4.74%, from a previous close of Rs 986.25 to the latest traded price of Rs 1,032.95, as of 17 November 2026 at 10:07 AM IST.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Aarti_Pharmalabs_hitting_new_52-week_highs\"><\/span><strong>Why is Aarti Pharmalabs hitting new 52-week highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> According to Univest data, the repeated one-year highs are confirmed as a price pattern, but no company-specific catalyst is established. The Aarti Pharmalabs 52 Week High Streak should therefore be read as a price event and not as a response to a confirmed development.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Aarti_Pharmalabs_share_price_today\"><\/span><strong>What is the Aarti Pharmalabs share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Pharmalabs was trading at Rs 1,032.95 as of 17 November 2026 at 10:07 AM IST, up 4.74% from the previous close of Rs 986.25. The day&#39;s range so far is Rs 980.20 to Rs 1,033.60.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Aarti_Pharmalabs_market_cap\"><\/span><strong>What is the Aarti Pharmalabs market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Pharmalabs has a market capitalisation of Rs 9,062.09 crore as of 17 November 2026. Market capitalisation indicates company size and not quality, so the Aarti Pharmalabs 52 Week High Streak should be read alongside P\/E, P\/B, ROE and ROCE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_PE_and_PB_ratios_of_Aarti_Pharmalabs\"><\/span><strong>What are the P\/E and P\/B ratios of Aarti Pharmalabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aarti Pharmalabs has a P\/E ratio of 34.84 and a P\/B ratio of 3.97. EPS is Rs 28.31 and book value is Rs 248.65, unchanged across the streak, so the change in both multiples comes from the share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Aarti_Pharmalabs_compare_with_the_Pharmaceuticals_Drugs_industry\"><\/span><strong>How does Aarti Pharmalabs compare with the Pharmaceuticals &amp; Drugs industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Its P\/E of 34.84 is 14.79% above the same-industry median of 30.35, and its P\/B of 3.97 is 36.9% above the median of 2.9. ROE of 8.50% is 25.63% below the industry median of 11.43%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Aarti_Pharmalabs_compare_with_its_peers\"><\/span><strong>How does Aarti Pharmalabs compare with its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among the five peers shown, P\/E ranges from 14.74 to 91.71, so Aarti Pharmalabs&#39;s 34.84 is above four of them. Its ROE of 8.50% and ROCE of 10.77% are below all five peers, and its P\/B of 3.97 is above one peer.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Aarti_Pharmalabs_Ltd_AARTIPHARM_Share_Price_on_Univest\"><\/span><strong>Track Aarti Pharmalabs Ltd. (AARTIPHARM) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\">Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"How many sessions has Aarti Pharmalabs set a 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aarti Pharmalabs has set a fresh 52-week high for its second straight session, on 16 November 2026 and again on 17 November 2026. The current 52-week high is Rs 1,033.60, and the Aarti Pharmalabs 52 Week High Streak is two sessions old as of 10:07.\"}},{\"@type\":\"Question\",\"name\":\"What is the Aarti Pharmalabs 52 Week High Streak gain?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the Aarti Pharmalabs 52 Week High Streak is 3.36%. Today's change is Rs 46.70, or 4.74%, from a previous close of Rs 986.25 to the latest traded price of Rs 1,032.95, as of 17 November 2026 at 10:07 AM IST.\"}},{\"@type\":\"Question\",\"name\":\"Why is Aarti Pharmalabs hitting new 52-week highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to Univest data, the repeated one-year highs are confirmed as a price pattern, but no company-specific catalyst is established. The Aarti Pharmalabs 52 Week High Streak should therefore be read as a price event and not as a response to a confirmed development.\"}},{\"@type\":\"Question\",\"name\":\"What is the Aarti Pharmalabs share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aarti Pharmalabs was trading at Rs 1,032.95 as of 17 November 2026 at 10:07 AM IST, up 4.74% from the previous close of Rs 986.25. The day's range so far is Rs 980.20 to Rs 1,033.60.\"}},{\"@type\":\"Question\",\"name\":\"What is the Aarti Pharmalabs market cap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aarti Pharmalabs has a market capitalisation of Rs 9,062.09 crore as of 17 November 2026. Market capitalisation indicates company size and not quality, so the Aarti Pharmalabs 52 Week High Streak should be read alongside P\/E, P\/B, ROE and ROCE.\"}},{\"@type\":\"Question\",\"name\":\"What are the P\/E and P\/B ratios of Aarti Pharmalabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aarti Pharmalabs has a P\/E ratio of 34.84 and a P\/B ratio of 3.97. EPS is Rs 28.31 and book value is Rs 248.65, unchanged across the streak, so the change in both multiples comes from the share price.\"}},{\"@type\":\"Question\",\"name\":\"How does Aarti Pharmalabs compare with the Pharmaceuticals & Drugs industry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its P\/E of 34.84 is 14.79% above the same-industry median of 30.35, and its P\/B of 3.97 is 36.9% above the median of 2.9. ROE of 8.50% is 25.63% below the industry median of 11.43%.\"}},{\"@type\":\"Question\",\"name\":\"How does Aarti Pharmalabs compare with its peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among the five peers shown, P\/E ranges from 14.74 to 91.71, so Aarti Pharmalabs's 34.84 is above four of them. Its ROE of 8.50% and ROCE of 10.77% are below all five peers, and its P\/B of 3.97 is above one peer.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aarti Pharmalabs Ltd. Share Price hit a fresh 52-week high of Rs 1,033.60 today and is trading at Rs 1,032.95, up 4.74% on the day. Market cap stands at Rs 9,062.09 crore.<\/p>\n","protected":false},"author":35,"featured_media":349519,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-349521","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["349519"],"rank_math_title":["Aarti Pharmalabs 52 Week High Streak: Second Straight High"],"rank_math_description":["Aarti Pharmalabs 52 Week High Streak: Aarti Pharmalabs has set a fresh 52-week high for the second straight session. Read the cumulative 3.36% move, P\/E, P\/B"],"rank_math_focus_keyword":["Aarti Pharmalabs 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Aarti_Pharmalabs_AARTIPHARM_52_Week_High_Streak_Stock_Hits_Fresh_High_for_Second_Straight_Session_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=349521"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349521\/revisions"}],"predecessor-version":[{"id":349523,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/349521\/revisions\/349523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/349519"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=349521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=349521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=349521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}